Skip to content

M-Vizion Femoral Revision System 01.22.004Recalls & reported problems

Medacta International SA · Proximal Body Ø20mm L 70mm STD · Class 2 · Implant

All models of M-Vizion Femoral Revision System (30)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07630971240827), received between Mar 29, 2023 and Mar 29, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Loosening of Implant Not Related to Bone-Ingrowth1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 29, 2023Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth

    AT ABOUT 1 YEAR 2 MONTHS AFTER THE PRIMARY, REVISION SURGERY PERFORMED DUE TO M-VIZION STEM SUBSIDENCE. THE SURGEON REVISED SUCCESSFULLY THE PROXIMAL BODY (70 TO 90 MM).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16635896 ↗

Other Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented devices

All Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page